C76.0 K12.28
Conditions
Interventions
Group 1: Determination of circulating Hsp70, SCCA, CEA, CTCs and immunophenotyping of lymphocytes in patients with head and neck tumors at t0 (preoperative), t1 (7 days postoperative), t2 (3 months po
Sponsors
Klinikum rechts der Isar, Klinik und Poliklinik für Mund-, Kiefer und Gesichtschirurgie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients with primary squamous cell carcinoma or other tumor entities and abscesses who underwent surgery/therapy in the Department of Oral and Maxillofacial Surgery at the Technical University of Munich as well as healthy volunteers who signed the informed consent to study participation.
Exclusion criteria
Exclusion criteria: - Patients without tumor disease or abscesses - Patients with external tumor aftercare
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of potential biomarkers: Determination of circulating Hsp70, SCCA, CEA, CTCs and immunophenotyping of lymphocytes in patients with head and neck cancer, in patients with abscesses and in healthy individuals until February 2027 | — |
Secondary
| Measure | Time frame |
|---|---|
| Recording of general patient data and forms of therapy | — |
Countries
Germany
Contacts
Public ContactMinli Niu
Klinikum rechts der Isar, Klinik und Poliklinik für Mund-, Kiefer und Gesichtschirurgie
Outcome results
None listed